loperamide-simethicone + matching placebo

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
85
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Diarrhea

Conditions

Diarrhea

Trial Timeline

Oct 1, 2008 โ†’ Oct 1, 2008

About loperamide-simethicone + matching placebo

loperamide-simethicone + matching placebo is a approved stage product being developed by Johnson & Johnson for Diarrhea. The current trial status is completed. This product is registered under clinical trial identifier NCT00685607. Target conditions include Diarrhea.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00685607ApprovedCompleted